Patatin-like phospholipase domain-containing 3 (PNPLA3) variants rs 738408 and rs 738409 single nucleotide polymorphism as predictor of metabolic associated fatty liver disease and its progression
Authors:
Open Access
- 2 May 2025
- journal article
- Published by Pakistan Journal of Medical Sciences in Pakistan Journal of Medical Sciences
- Vol. 41 (5) , 1322-1330
Abstract
Objective: To identify the PNPLA3 genetic variants as the potential predictors for metabolic associated fatty liver disease (MAFLD) and its progression among Pakistani population. Method: A cross sectional study comprising of 158 participants. They were included in this study with non-probability purposive sampling technique from Radiology Department of Aziz Fatimah Teaching Hospital and Aziz Fatimah Medical and Dental College, Pakistan. The duration of study was December 5, 2021 to April 4, 2024. Blood samples (10mL) were drawn for liver enzymes, gene analysis and ultimately PCR products were sent for Sanger sequencing. Data was analyzed using SPSS version 26 with p-Values ≤0.05 considered significant. Results: From 158 studied participants, 43.7% were male, and 56.3% were female. Of total population 51.3% were MAFLD positive while 48.7% were control subjects. Present results showed that CT and TT genotypes of rs738408 were frequently found in MAFLD group (p=0.039 and 0.060, respectively) and significant predictor for developing MAFLD (OR=2.484, p=0.019 and OR=5.167, p<0.001, respectively). Concerning progression of the disease CT genotype showed that subject with this genotype progress to moderate grade of fatty liver disease (OR=2.832, p=0.013). Whereas Odd ratio for TT genotype was significant for severe grade fatty liver diseases (OR=15.50, p=0.007). GG genotype of rs738409 was frequently found in MAFLD group (p=0.032). Odds ratio for GG genotype of rs738409 was significant for developing MAFLD (OR=4.565, p=0.025) and responsible to progress to moderate grade of fatty liver disease (OR= 5.083, p=0.022). Conclusion: CT and TT genotypes of 738408 and GG genotype of 738409 are associated with MAFLD and are at more risk for disease progression. doi: https://doi.org/10.12669/pjms.41.5.11532 How to cite this: Altaf B, Jawed S, Ghazali WSW, Aziz AAA, Salam RMT, Rasheed A, et al. Patatin-like phospholipase domain-containing 3 (PNPLA3) variants rs 738408 and rs 738409 single nucleotide polymorphism as predictor of metabolic associated fatty liver disease and its progression. Pak J Med Sci. 2025;41(5):1322-1330. doi: https://doi.org/10.12669/pjms.41.5.11532 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Keywords
This publication has 25 references indexed in Scilit:
- PNPLA3 rs738409 C>G Variant Predicts Fibrosis Progression by Noninvasive Tools in Nonalcoholic Fatty Liver DiseaseClinical Gastroenterology and Hepatology, 2021
- Metabolic-associated fatty liver disease and lipoprotein metabolismMolecular Metabolism, 2021
- A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statementJournal of Hepatology, 2020
- Genetic variants that associate with cirrhosis have pleiotropic effects on human traitsLiver International, 2019
- Validation of PNPLA3 polymorphisms as risk factor for NAFLD and liver fibrosis in an admixed populationAnnals of Hepatology, 2019
- Biochemical markers and lipid profile in nonalcoholic fatty liver disease patients in the PERSIAN Guilan cohort study (PGCS), IranJournal of Family Medicine and Primary Care, 2019
- New insights into genetic predisposition and novel therapeutic targets for nonalcoholic fatty liver diseaseHepatoBiliary Surgery and Nutrition, 2018
- Is Nonalcoholic Fatty Liver Disease Indeed the Hepatic Manifestation of Metabolic Syndrome?Current Vascular Pharmacology, 2018
- The PNPLA3 variant associated with fatty liver disease (I148M) accumulates on lipid droplets by evading ubiquitylationHepatology, 2017
- The Genetics of Nonalcoholic Fatty Liver Disease: Spotlight on PNPLA3 and TM6SF2Seminars in Liver Disease, 2015